Rituximab and pemphigus--a therapeutic advance.
Luis A
LA
Diaz
D000906:Antibodies / Q000502:physiology; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001327:Autoimmune Diseases / Q000188:drug therapy; D001402:B-Lymphocytes / Q000502:physiology; D051182:Desmogleins / Q000276:immunology; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D010392:Pemphigus / Q000188:drug therapy* / Q000276:immunology; D000069283:Rituximab
D000906:Antibodies; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D051182:Desmogleins; D007155:Immunologic Factors; D000069283:Rituximab